Annual Short Term Debt
$6.44 M
+$816.00 K+14.51%
31 December 2023
Summary:
Apellis Pharmaceuticals annual short term debt is currently $6.44 million, with the most recent change of +$816.00 thousand (+14.51%) on 31 December 2023. During the last 3 years, it has risen by +$2.76 million (+74.79%). APLS annual short term debt is now at all-time high.APLS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$6.79 M
+$578.00 K+9.30%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly short term debt is currently $6.79 million, with the most recent change of +$578.00 thousand (+9.30%) on 30 September 2024. Over the past year, it has increased by +$1.05 million (+18.35%). APLS quarterly short term debt is now at all-time high.APLS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.5% | +18.4% |
| 3 y3 years | +74.8% | +66.8% |
| 5 y5 years | +286.4% | +194.8% |
APLS Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +74.8% | at high | +66.8% |
| 5 y | 5 years | at high | +286.4% | at high | +194.8% |
| alltime | all time | at high | +286.4% | at high | +502.3% |
Apellis Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.79 M(+9.3%) |
| June 2024 | - | $6.21 M(-0.7%) |
| Mar 2024 | - | $6.26 M(-2.9%) |
| Dec 2023 | $6.44 M(+14.5%) | $6.44 M(+12.2%) |
| Sept 2023 | - | $5.74 M(-1.9%) |
| June 2023 | - | $5.85 M(+0.4%) |
| Mar 2023 | - | $5.83 M(+3.6%) |
| Dec 2022 | $5.63 M(+36.7%) | $5.63 M(+3.7%) |
| Sept 2022 | - | $5.42 M(+2.1%) |
| June 2022 | - | $5.31 M(+16.5%) |
| Mar 2022 | - | $4.56 M(+10.8%) |
| Dec 2021 | $4.12 M | $4.12 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $4.07 M(+0.9%) |
| June 2021 | - | $4.04 M(+3.4%) |
| Mar 2021 | - | $3.90 M(+5.9%) |
| Dec 2020 | $3.69 M(+41.2%) | $3.69 M(+7.2%) |
| Sept 2020 | - | $3.44 M(+29.1%) |
| June 2020 | - | $2.66 M(-2.5%) |
| Mar 2020 | - | $2.73 M(+4.7%) |
| Dec 2019 | $2.61 M(+56.5%) | $2.61 M(+13.2%) |
| Sept 2019 | - | $2.30 M(+48.7%) |
| June 2019 | - | $1.55 M(+37.4%) |
| Mar 2019 | - | $1.13 M(-32.3%) |
| Dec 2018 | $1.67 M | $1.67 M |
FAQ
- What is Apellis Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual short term debt year-on-year change?
- What is Apellis Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly short term debt year-on-year change?
What is Apellis Pharmaceuticals annual short term debt?
The current annual short term debt of APLS is $6.44 M
What is the all time high annual short term debt for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual short term debt is $6.44 M
What is Apellis Pharmaceuticals annual short term debt year-on-year change?
Over the past year, APLS annual short term debt has changed by +$816.00 K (+14.51%)
What is Apellis Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of APLS is $6.79 M
What is the all time high quarterly short term debt for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly short term debt is $6.79 M
What is Apellis Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, APLS quarterly short term debt has changed by +$1.05 M (+18.35%)